» Articles » PMID: 31357624

Interrogating the Essential Bacterial Cell Division Protein FtsQ with Fragments Using Target Immobilized NMR Screening (TINS)

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jul 31
PMID 31357624
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The divisome is a large protein complex that regulates bacterial cell division and therefore represents an attractive target for novel antibacterial drugs. In this study, we report on the ligandability of FtsQ, which is considered a key component of the divisome. For this, the soluble periplasmic domain of FtsQ was immobilized and used to screen a library of 1501 low molecular weight (< 300 Da), synthetic compounds for those that interact with the protein. A primary screen was performed using target immobilized NMR screening (TINS) and yielded 72 hits. Subsequently, these hits were validated in an orthogonal assay. At first, we aimed to do this using surface plasmon resonance (SPR), but the lack of positive control hampered optimization of the experiment. Alternatively, a two-dimensional heteronuclear single quantum coherence (HSQC) NMR spectrum of FtsQ was obtained and used to validate these hits by chemical shift perturbation (CSP) experiments. This resulted in the identification of three fragments with weak affinity for the periplasmic domain of FtsQ, arguing that the ligandability of FtsQ is low. While this indicates that developing high affinity ligands for FtsQ is far from straightforward, the identified hit fragments can help to further interrogate FtsQ interactions.

Citing Articles

Covalent Proteomimetic Inhibitor of the Bacterial FtsQB Divisome Complex.

Paulussen F, Schouten G, Moertl C, Verheul J, Hoekstra I, Koningstein G J Am Chem Soc. 2022; 144(33):15303-15313.

PMID: 35945166 PMC: 9413201. DOI: 10.1021/jacs.2c06304.


Filamentous Thermosensitive Mutant Z: An Appealing Target for Emerging Pathogens and a Trek on Its Natural Inhibitors.

Gurnani M, Chauhan A, Ranjan A, Tuli H, Alkhanani M, Haque S Biology (Basel). 2022; 11(5).

PMID: 35625352 PMC: 9138142. DOI: 10.3390/biology11050624.


NMR in target driven drug discovery: why not?.

Keiffer S, Carneiro M, Hollander J, Kobayashi M, Pogoryelev D, Ab E J Biomol NMR. 2020; 74(10-11):521-529.

PMID: 32901320 PMC: 7683447. DOI: 10.1007/s10858-020-00343-9.

References
1.
Hann M, Leach A, Harper G . Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci. 2001; 41(3):856-64. DOI: 10.1021/ci000403i. View

2.
OShannessy D, Brigham-Burke M, Peck K . Immobilization chemistries suitable for use in the BIAcore surface plasmon resonance detector. Anal Biochem. 1992; 205(1):132-6. DOI: 10.1016/0003-2697(92)90589-y. View

3.
Congreve M, Carr R, Murray C, Jhoti H . A 'rule of three' for fragment-based lead discovery?. Drug Discov Today. 2003; 8(19):876-7. DOI: 10.1016/s1359-6446(03)02831-9. View

4.
Arkin M, Wells J . Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov. 2004; 3(4):301-17. DOI: 10.1038/nrd1343. View

5.
Buddelmeijer N, Beckwith J . A complex of the Escherichia coli cell division proteins FtsL, FtsB and FtsQ forms independently of its localization to the septal region. Mol Microbiol. 2004; 52(5):1315-27. DOI: 10.1111/j.1365-2958.2004.04044.x. View